Paxlovid decreased hospitalisation, risk of death during Omicron wave: Research
The research, published in the Canadian Medical Association Journal, aimed to evaluate the effectiveness of paxlovid, a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
nirmatrelvir
Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment
Hetero’s ‘NIRMACOM’ (Nirmatrelvir), a generic version of Pfizer’s COVID-19 oral antiviral drug ‘PAXLOVID’is co-packaged with…
WHO recommends Pfizer’s Paxlovid for wide geographical distribution
Pfizer’s oral antiviral drug (a combination of Nirmatrelvir and Ritonavir tablets) is strongly recommended for patients with…
35 generic manufacturers sign agreements with MPP to produce generic versions of Pfizer’s…
The sublicence agreements are the result of the voluntary licensing agreement signed by MPP and Pfizer in November 2021 that will…
‘TRIPS Waiver’ must be agreed now, says MSF
Access needs to be ensured for not just COVID-19 vaccines, but all COVID-19 medical tools, for everyone, everywhere